FEEDUP, takes off as a bio enterprise utilizing “microorganisms in intestine” Analyzed the genome of fermented soybean strain ‘SLB130’
페이지 정보
Writer 최고관리자 Date 20-06-10 09:34 inquiry 906th본문
This article was posted on thebell’s paid subscribers’ page on Jan 14, 2019 at 09:54.
Animal feed manufacturer FEEDUP completed the analyzation of fermented soybean strain genome. Utilizing such analysis, FEEDUP plans to promote itself to a bio enterprise that develops the treatment for illness like Atopic dermatitis and colon cancer.
FEEDUP announced that they have completed the analysis of entire genome of SLB130, its patented lactic acid bacteria.’SLB130’ is lactic acid bacteria used for fermenting the oil extracted soybeans. Fermented soybean feeds have twice more nutrients than the regular soybeans, and it has high digestibility, so it is often used for animal feeds.
‘SLB130’ that was recently completed of its genome analysis is lactic acid bacteria originated from human and animals’ intestines. It prevents the disease in intestines and promotes growth. FEEDUP analyzed its genome through NGS (Next generation sequencing) method. Now, they have the ability to obtain the gene data that are needed for a long term research development for such as body treatment and the gene data that can be productized through a short term research and development for animal medication and functional products.
